NEW YORK — Chain Drug Review readers are invited to a timely and thought-provoking webinar exploring the critical role of generic drugs in the U.S. healthcare system. Titled “Generics at a Crossroad,” the 30-minute webcast will take place on Tuesday, July 8, 2025, at 1:00 p.m. EDT and will feature prominent voices from Ascend Laboratories.
Generics account for more than 90% of prescriptions filled nationwide, saving the healthcare system $445 billion in 2023 alone. Yet, the sector faces mounting challenges—supply chain disruptions, tightening margins, and questions about long-term sustainability.
The webinar will feature expert insights from John Dillaway, Executive Vice President of Ascend Laboratories, and Amit Ghare, also of Ascend. Attendees will gain a deeper understanding of:
- The evolving generics business landscape
- Barriers to bringing generics to market
- Systemic reforms needed for viability
- How Ascend continues to differentiate itself in a crowded marketplace
Moderated by Jeff Woldt, Editor-in-Chief of retailmediaIQ, Mass Market Retailers and Chain Drug Review, the session promises a candid conversation about the forces shaping one of healthcare’s most vital segments.
Register now to secure your place and learn what’s next for generics, and why it matters to every link in the pharmacy supply chain.
